Login
Home
Charts
Search
Watchlist
Products

Anuh Pharma Ltd

ANUHPHR·BSE
93.20-0.31%Tue, 22 Sept '26 15:29

Anuh Pharma Ltd

ANUHPHR
BSE
93.20
-0.31%
|Tue, 22 Sept '26 15:29
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
934Cr
Close
Close Price
93.20
Industry
Industry
Pharma - API
PE
Price To Earnings
21.13
PS
Price To Sales
1.20
Revenue
Revenue
779Cr
Rev Gr TTM
Revenue Growth TTM
9.70%
PAT Gr TTM
PAT Growth TTM
-4.29%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
150172164138166160198186186197202194
Growth YoY
Revenue Growth YoY%
29.924.14.2-14.611.0-7.320.935.212.023.62.03.9
Expenses
ExpensesCr
132148145127149145179176174178182178
Operating Profit
Operating ProfitCr
182419111715191012192016
OPM
OPM%
12.013.911.77.710.29.39.45.56.49.79.88.4
Other Income
Other IncomeCr
2434311312-13
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222333332
PBT
PBTCr
182520121813171110181617
Tax
TaxCr
464333532446
PAT
PATCr
1419151015101288131211
Growth YoY
PAT Growth YoY%
39.4105.359.7-19.18.8-45.9-18.9-12.7-49.430.1-6.337.6
NPM
NPM%
9.311.19.46.99.16.56.34.54.16.85.85.9
EPS
EPS
1.41.91.50.91.51.01.30.80.81.31.21.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
150172164138166160198186186197202194
Growth YoY
Revenue Growth YoY%
29.924.14.2-14.611.0-7.320.935.212.023.62.03.9
Expenses
ExpensesCr
132148145127149145179176174178182178
Operating Profit
Operating ProfitCr
182419111715191012192016
OPM
OPM%
12.013.911.77.710.29.39.45.56.49.79.88.4
Other Income
Other IncomeCr
2434311312-13
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222333332
PBT
PBTCr
182520121813171110181617
Tax
TaxCr
464333532446
PAT
PATCr
1419151015101288131211
Growth YoY
PAT Growth YoY%
39.4105.359.7-19.18.8-45.9-18.9-12.7-49.430.1-6.337.6
NPM
NPM%
9.311.19.46.99.16.56.34.54.16.85.85.9
EPS
EPS
1.41.91.50.91.51.01.30.80.81.31.21.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
326206238321307432487527647662772779
Growth
Revenue Growth%
15.0-36.815.534.7-4.340.712.78.422.72.216.69.7
Expenses
ExpensesCr
289184220291284387440476572601710712
Operating Profit
Operating ProfitCr
372218302345475175616267
OPM
OPM%
11.310.77.59.27.410.39.69.711.69.28.08.6
Other Income
Other IncomeCr
48754115612945
Interest Expense
Interest ExpenseCr
000011100100
Depreciation
DepreciationCr
22227151210991111
PBT
PBTCr
382823321939394778615460
Tax
TaxCr
1287951091118141316
PAT
PATCr
262017231428313660474144
Growth
PAT Growth%
17.3-22.3-17.641.5-38.898.87.518.466.0-21.2-13.3-4.3
NPM
NPM%
7.99.76.97.34.76.66.36.99.37.25.35.7
EPS
EPS
2.62.01.62.30.72.83.03.66.04.74.14.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
326206238321307432487527647662772779
Growth
Revenue Growth%
15.0-36.815.534.7-4.340.712.78.422.72.216.69.7
Expenses
ExpensesCr
289184220291284387440476572601710712
Operating Profit
Operating ProfitCr
372218302345475175616267
OPM
OPM%
11.310.77.59.27.410.39.69.711.69.28.08.6
Other Income
Other IncomeCr
48754115612945
Interest Expense
Interest ExpenseCr
000011100100
Depreciation
DepreciationCr
22227151210991111
PBT
PBTCr
382823321939394778615460
Tax
TaxCr
1287951091118141316
PAT
PATCr
262017231428313660474144
Growth
PAT Growth%
17.3-22.3-17.641.5-38.898.87.518.466.0-21.2-13.3-4.3
NPM
NPM%
7.99.76.97.34.76.66.36.99.37.25.35.7
EPS
EPS
2.62.01.62.30.72.83.03.66.04.74.14.4

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1313131313252525252550
Reserves
ReservesCr
107128137152150166189216266301302
Current Liabilities
Current LiabilitiesCr
72475975163139131161153179203
Non Current Liabilities
Non Current LiabilitiesCr
11111332222
Total Liabilities
Total LiabilitiesCr
193189209240326333347405446507557
Current Assets
Current AssetsCr
151138154152223238259308339376451
Non Current Assets
Non Current AssetsCr
42515588103958897107130106
Total Assets
Total AssetsCr
193189209240326333347405446507557
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1313131313252525252550
Reserves
ReservesCr
107128137152150166189216266301302
Current Liabilities
Current LiabilitiesCr
72475975163139131161153179203
Non Current Liabilities
Non Current LiabilitiesCr
11111332222
Total Liabilities
Total LiabilitiesCr
193189209240326333347405446507557
Current Assets
Current AssetsCr
151138154152223238259308339376451
Non Current Assets
Non Current AssetsCr
42515588103958897107130106
Total Assets
Total AssetsCr
193189209240326333347405446507557

Cash Flow

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
749-1929541337-3
Investing Cash Flow
Investing Cash FlowCr
3-7752-8-431-2018
Financing Cash Flow
Financing Cash FlowCr
-722-33-19-12-9-5-26
Net Cash Flow
Net Cash FlowCr
3-502-2512-12
Free Cash Flow
Free Cash FlowCr
-2213-252752817-11
CFO To PAT
CFO To PAT%
30.5342.1-65.994.5149.021.578.4-7.3
CFO To EBITDA
CFO To EBITDA%
24.1214.9-42.061.6105.117.261.0-4.9
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
749-1929541337-3
Investing Cash Flow
Investing Cash FlowCr
3-7752-8-431-2018
Financing Cash Flow
Financing Cash FlowCr
-722-33-19-12-9-5-26
Net Cash Flow
Net Cash FlowCr
3-502-2512-12
Free Cash Flow
Free Cash FlowCr
-2213-252752817-11
CFO To PAT
CFO To PAT%
30.5342.1-65.994.5149.021.578.4-7.3
CFO To EBITDA
CFO To EBITDA%
24.1214.9-42.061.6105.117.261.0-4.9

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4945043923392924534313991,231746673934
Price To Earnings
Price To Earnings
19.125.523.814.520.415.914.111.020.515.816.421.1
Price To Sales
Price To Sales
1.52.51.61.10.91.10.90.81.91.10.91.2
Price To Book
Price To Book
4.13.62.62.11.82.42.01.64.22.31.92.6
EV To EBITDA
EV To EBITDA
13.122.621.611.214.710.08.97.716.312.110.813.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.920.118.218.819.118.517.518.019.216.815.315.3
OPM
OPM%
11.310.77.59.27.410.39.69.711.69.28.08.6
NPM
NPM%
7.99.76.97.34.76.66.36.99.37.25.35.7
ROCE
ROCE%
31.319.715.419.39.619.618.419.726.818.315.515.5
ROE
ROE%
21.614.311.014.28.814.914.315.020.614.511.711.7
ROA
ROA%
13.410.67.99.74.48.68.88.913.59.37.47.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4945043923392924534313991,231746673934
Price To Earnings
Price To Earnings
19.125.523.814.520.415.914.111.020.515.816.421.1
Price To Sales
Price To Sales
1.52.51.61.10.91.10.90.81.91.10.91.2
Price To Book
Price To Book
4.13.62.62.11.82.42.01.64.22.31.92.6
EV To EBITDA
EV To EBITDA
13.122.621.611.214.710.08.97.716.312.110.813.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.920.118.218.819.118.517.518.019.216.815.315.3
OPM
OPM%
11.310.77.59.27.410.39.69.711.69.28.08.6
NPM
NPM%
7.99.76.97.34.76.66.36.99.37.25.35.7
ROCE
ROCE%
31.319.715.419.39.619.618.419.726.818.315.515.5
ROE
ROE%
21.614.311.014.28.814.914.315.020.614.511.711.7
ROA
ROA%
13.410.67.99.74.48.68.88.913.59.37.47.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Anuh Pharma Ltd

  • Q3 FY2022 Earnings Call Transcript (Dec 2021, PDF): https://www.stockscans.in/document/ujqrc5ovosqgurpd7snfidk8.pdf
  • Q2 FY2022 Earnings Call Transcript (Sep 2021, PDF): https://www.stockscans.in/document/kgdtuaj5daha0o38isc85xml.pdf
  • Q1 FY2022 Earnings Call Transcript (Jun 2021, PDF): https://www.stockscans.in/document/lokypuhqf9evwl7d1ni86d8a.pdf
  • Q3 FY2021 Earnings Call Transcript (Dec 2020, PDF): https://www.stockscans.in/document/mt99xawd2z2hq8nw954mtlhs.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/5z47nhc4rel3shc0sjxm15oe.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/w7yngz7wwrovbkti7197gkwg.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/pp9ishu61e7ta64ltb20kng2.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ezef87cebqb9o3szhuy4g4h1.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/91k6o5vaocj22y6x0lo9qofm.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/p2746tvdehvyezro5vlacmi3.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/5n25b0t3jhivesfcniar13hn.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/nax3hzlz5fy1hir0nnw616ft.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/rgch733463w93wuredopflrm.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/jdq5cn2pfct3cmm1ifvfz28n.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/rtdfge2disa4w10woyqj3yix.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/h2v5ce3lzs9vd9ml8nn892us.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/72532vuznv7o0tigmldo7a6b.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/w5iwqd6ucoq3zkgzx7mge7le.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/8pz0z5fexaner0cftdcxdjf3.pdf
  • Q3 FY2024 Investor Presentation (Dec 2023, PDF): https://www.stockscans.in/document/n4fu2a2p3j7rhqd2q9cizjjo.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/py0d6vbk5xdh1rlxal5xsuin.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/x6xo0jfp3b435s6d71nw1it3.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/4gejs77q8z7ffe1r2xnlenvz.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/n7evn0gjm6oz09xhl7z9i01i.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/n0kst94jgfnqfn55nuywe6gc.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/33tvzl6in50ig1ltahho21pq.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/u8vkhujnsd3as149y00bq4j1.pdf